| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.038 | 0.8 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.8 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.033 | 0.8 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |